Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.5300
-0.0100 ( -1.85% ) 0.0K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.5300
Previous close
$0.5400
Volume
0.0K
Market cap
$84.34M
Day range
$0.5410 - $0.5420
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 94 | Feb 14, 2024 |
| 8-k | 8K-related | 18 | Feb 07, 2024 |
| 4 | Insider transactions | 1 | Feb 02, 2024 |
| 8-k | 8K-related | 13 | Jan 25, 2024 |
| 8-k | 8K-related | 42 | Jan 16, 2024 |
| 8-k | 8K-related | 12 | Jan 16, 2024 |
| prem14a | Proxies and info statements | 9 | Dec 22, 2023 |
| 8-k | 8K-related | 41 | Dec 01, 2023 |
| 10-q | Quarterly Reports | 62 | Nov 14, 2023 |
| 4 | Insider transactions | 1 | Nov 14, 2023 |